A detailed history of Thompson Investment Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Thompson Investment Management, Inc. holds 241,774 shares of EXAS stock, worth $12.9 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares
241,774
Previous 205,269 17.78%
Holding current value
$12.9 Million
Previous $14 Million 2.8%
% of portfolio
2.0%
Previous 2.07%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025

BUY
$49.33 - $71.97 $1.8 Million - $2.63 Million
36,505 Added 17.78%
241,774 $13.6 Million
Q3 2024

Oct 15, 2024

BUY
$42.43 - $70.83 $475,131 - $793,154
11,198 Added 5.77%
205,269 $14 Million
Q2 2024

Jul 08, 2024

BUY
$41.33 - $74.26 $1.38 Million - $2.49 Million
33,487 Added 20.85%
194,071 $8.2 Million
Q1 2024

Apr 12, 2024

BUY
$56.27 - $73.77 $1.05 Million - $1.37 Million
18,595 Added 13.1%
160,584 $11.1 Million
Q4 2023

Jan 16, 2024

BUY
$59.06 - $75.72 $11,280 - $14,462
191 Added 0.13%
141,989 $10.5 Million
Q3 2023

Oct 30, 2023

SELL
$65.94 - $99.04 $209,689 - $314,947
-3,180 Reduced 2.19%
141,798 $9.67 Million
Q2 2023

Jul 10, 2023

SELL
$62.68 - $95.05 $1.28 Million - $1.94 Million
-20,435 Reduced 12.35%
144,978 $13.6 Million
Q1 2023

Apr 24, 2023

SELL
$47.19 - $70.77 $1.48 Million - $2.21 Million
-31,280 Reduced 15.9%
165,413 $11.2 Million
Q4 2022

Jan 20, 2023

SELL
$30.35 - $53.15 $69,349 - $121,447
-2,285 Reduced 1.15%
196,693 $9.74 Million
Q3 2022

Oct 17, 2022

BUY
$31.97 - $49.37 $1.57 Million - $2.42 Million
49,059 Added 32.72%
198,978 $6.47 Million
Q2 2022

Aug 05, 2022

BUY
$35.61 - $76.23 $539,562 - $1.16 Million
15,152 Added 11.24%
149,919 $5.91 Million
Q1 2022

Apr 20, 2022

BUY
$57.56 - $82.54 $566,447 - $812,276
9,841 Added 7.88%
134,767 $9.42 Million
Q4 2021

Feb 07, 2022

BUY
$72.5 - $100.68 $766,760 - $1.06 Million
10,576 Added 9.25%
124,926 $9.72 Million
Q3 2021

Oct 13, 2021

SELL
$90.24 - $124.05 $64,160 - $88,199
-711 Reduced 0.62%
114,350 $10.9 Million
Q2 2021

Aug 10, 2021

SELL
$93.66 - $139.27 $84,762 - $126,039
-905 Reduced 0.78%
115,061 $14.3 Million
Q1 2021

Apr 07, 2021

SELL
$116.57 - $155.01 $2.18 Million - $2.9 Million
-18,696 Reduced 13.88%
115,966 $15.3 Million
Q4 2020

Jan 19, 2021

SELL
$99.61 - $142.12 $2.05 Million - $2.92 Million
-20,549 Reduced 13.24%
134,662 $17.8 Million
Q3 2020

Oct 13, 2020

SELL
$72.92 - $102.01 $180,185 - $252,066
-2,471 Reduced 1.57%
155,211 $15.8 Million
Q2 2020

Jul 23, 2020

SELL
$55.75 - $92.75 $255,390 - $424,887
-4,581 Reduced 2.82%
157,682 $13.7 Million
Q1 2020

Apr 23, 2020

BUY
$37.9 - $104.44 $1.66 Million - $4.58 Million
43,895 Added 37.08%
162,263 $9.41 Million
Q4 2019

Feb 06, 2020

BUY
$77.66 - $99.74 $1.33 Million - $1.71 Million
17,118 Added 16.91%
118,368 $10.9 Million
Q3 2019

Nov 04, 2019

SELL
$90.37 - $122.49 $3 Million - $4.07 Million
-33,239 Reduced 24.72%
101,250 $9.15 Million
Q2 2019

Aug 07, 2019

SELL
$89.51 - $118.04 $2.12 Million - $2.8 Million
-23,692 Reduced 14.98%
134,489 $15.9 Million
Q1 2019

Apr 24, 2019

SELL
$61.98 - $96.5 $512,822 - $798,441
-8,274 Reduced 4.97%
158,181 $13.7 Million
Q4 2018

Feb 04, 2019

SELL
$56.04 - $82.66 $1.29 Million - $1.9 Million
-22,949 Reduced 12.12%
166,455 $10.5 Million
Q3 2018

Nov 06, 2018

SELL
$48.29 - $80.6 $1.59 Million - $2.66 Million
-33,025 Reduced 14.85%
189,404 $14.9 Million
Q2 2018

Jul 09, 2018

SELL
$37.84 - $69.96 $1.22 Million - $2.26 Million
-32,316 Reduced 12.69%
222,429 $13.3 Million
Q1 2018

May 04, 2018

BUY
$39.82 - $57.53 $1.15 Million - $1.66 Million
28,915 Added 12.8%
254,745 $10.3 Million
Q4 2017

Feb 02, 2018

SELL
$46.49 - $60.51 $2.18 Million - $2.83 Million
-46,831 Reduced 17.18%
225,830 $11.9 Million
Q3 2017

Nov 07, 2017

BUY
$37.05 - $47.12 $10.1 Million - $12.8 Million
272,661
272,661 $12.8 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $9.47B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Thompson Investment Management, Inc. Portfolio

Follow Thompson Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Thompson Investment Management, Inc. with notifications on news.